RAC1 and amyotrophic lateral sclerosis: This mutation/deletion reduces actin dynamics in motor neurons and activates Arf6 which effectively leads to the activation of the downstream effector Rac1 (Sivadasan et al., 2016), again supporting the benefits of inhibit Rac1 activity in treating ALS.